250 related articles for article (PubMed ID: 28420650)
21. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
Basciano H; Miller A; Baker C; Naples M; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
[TBL] [Abstract][Full Text] [Related]
22. Liver X receptor agonist methyl-3β-hydroxy-5α,6α-epoxycholanate attenuates atherosclerosis in apolipoprotein E knockout mice without increasing plasma triglyceride.
Yan W; Zhang T; Cheng J; Zhou X; Qu X; Hu H
Pharmacology; 2010; 86(5-6):306-12. PubMed ID: 21071998
[TBL] [Abstract][Full Text] [Related]
23. Ursolic Acid, a Novel Liver X Receptor α (LXRα) Antagonist Inhibiting Ligand-Induced Nonalcoholic Fatty Liver and Drug-Induced Lipogenesis.
Lin YN; Wang CCN; Chang HY; Chu FY; Hsu YA; Cheng WK; Ma WC; Chen CJ; Wan L; Lim YP
J Agric Food Chem; 2018 Nov; 66(44):11647-11662. PubMed ID: 30359008
[TBL] [Abstract][Full Text] [Related]
24. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
[TBL] [Abstract][Full Text] [Related]
25. 4-cholesten-3-one decreases breast cancer cell viability and alters membrane raft-localized EGFR expression by reducing lipogenesis and enhancing LXR-dependent cholesterol transporters.
Elia J; Carbonnelle D; Logé C; Ory L; Huvelin JM; Tannoury M; Diab-Assaf M; Petit K; Nazih H
Lipids Health Dis; 2019 Sep; 18(1):168. PubMed ID: 31477154
[TBL] [Abstract][Full Text] [Related]
26. Cilostazol inhibits insulin-stimulated expression of sterol regulatory binding protein-1c via inhibition of LXR and Sp1.
Jung YA; Kim HK; Bae KH; Seo HY; Kim HS; Jang BK; Jung GS; Lee IK; Kim MK; Park KG
Exp Mol Med; 2014 Jan; 46(1):e73. PubMed ID: 24458133
[TBL] [Abstract][Full Text] [Related]
27. The role of LXR alpha in goose primary hepatocyte lipogenesis.
Han C; Wang J; Li L; Wang L; Zhang Z
Mol Cell Biochem; 2009 Feb; 322(1-2):37-42. PubMed ID: 18975056
[TBL] [Abstract][Full Text] [Related]
28. Gestational diabetes mellitus modulates cholesterol homeostasis in human fetoplacental endothelium.
Sun Y; Kopp S; Strutz J; Gali CC; Zandl-Lang M; Fanaee-Danesh E; Kirsch A; Cvitic S; Frank S; Saffery R; Björkhem I; Desoye G; Wadsack C; Panzenboeck U
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):968-979. PubMed ID: 29778664
[TBL] [Abstract][Full Text] [Related]
29. Nrf2 inhibits LXRα-dependent hepatic lipogenesis by competing with FXR for acetylase binding.
Kay HY; Kim WD; Hwang SJ; Choi HS; Gilroy RK; Wan YJ; Kim SG
Antioxid Redox Signal; 2011 Oct; 15(8):2135-46. PubMed ID: 21504366
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of gomisin N against hepatic steatosis through AMPK activation.
Yun YR; Kim JH; Kim JH; Jung MH
Biochem Biophys Res Commun; 2017 Jan; 482(4):1095-1101. PubMed ID: 27914812
[TBL] [Abstract][Full Text] [Related]
31. The effects of LXR agonist T0901317 and LXR antagonist GSK2033 on morphogenesis and lipid properties in full thickness skin models.
Helder RWJ; Boiten WA; van Dijk R; Gooris GS; El Ghalbzouri A; Bouwstra JA
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158546. PubMed ID: 31678517
[TBL] [Abstract][Full Text] [Related]
32. Activation of liver X receptor promotes fatty acid synthesis in goat mammary epithelial cells via modulation of SREBP1 expression.
Xu HF; Luo J; Zhang XY; Li J; Bionaz M
J Dairy Sci; 2019 Apr; 102(4):3544-3555. PubMed ID: 30738675
[TBL] [Abstract][Full Text] [Related]
33. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
34. Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.
Green CD; Jump DB; Olson LK
Endocrinology; 2009 Jun; 150(6):2637-45. PubMed ID: 19228891
[TBL] [Abstract][Full Text] [Related]
35. Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule.
Zhang Y; Zhang X; Chen L; Wu J; Su D; Lu WJ; Hwang MT; Yang G; Li S; Wei M; Davis L; Breyer MD; Guan Y
Am J Physiol Renal Physiol; 2006 May; 290(5):F1065-73. PubMed ID: 16368743
[TBL] [Abstract][Full Text] [Related]
36. Increased lipogenesis and stearate accelerate vascular calcification in calcifying vascular cells.
Ting TC; Miyazaki-Anzai S; Masuda M; Levi M; Demer LL; Tintut Y; Miyazaki M
J Biol Chem; 2011 Jul; 286(27):23938-49. PubMed ID: 21596756
[TBL] [Abstract][Full Text] [Related]
37. Tissue-specific autoregulation of the LXRalpha gene facilitates induction of apoE in mouse adipose tissue.
Ulven SM; Dalen KT; Gustafsson JA; Nebb HI
J Lipid Res; 2004 Nov; 45(11):2052-62. PubMed ID: 15292368
[TBL] [Abstract][Full Text] [Related]
38. The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse.
Chisholm JW; Hong J; Mills SA; Lawn RM
J Lipid Res; 2003 Nov; 44(11):2039-48. PubMed ID: 12923232
[TBL] [Abstract][Full Text] [Related]
39. Oleate activates SREBP-1 signaling activity in
Lounis MA; Bergeron KF; Burhans MS; Ntambi JM; Mounier C
Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E710-E720. PubMed ID: 28851735
[TBL] [Abstract][Full Text] [Related]
40. n-3 fatty acids ameliorate hepatic steatosis and dysfunction after LXR agonist ingestion in mice.
Jung UJ; Millman PN; Tall AR; Deckelbaum RJ
Biochim Biophys Acta; 2011 Sep; 1811(9):491-7. PubMed ID: 21704188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]